PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1990Circulation258 citations

Long-term results of catheter ablation of idiopathic right ventricular tachycardia.

View Full Paper
FMFred MoradyAKAlan H. KadishLDLorenzo A. DiCarlo

Structured PICO

Does catheter ablation prevent recurrence of symptomatic VT in patients with idiopathic right ventricular tachycardia?

P
Population
10 consecutive patients with recurrent episodes of symptomatic, idiopathic, sustained monomorphic ventricular tachycardia (VT) originating in the right ventricle, with no evidence of structural heart disease. Mean age 39 +/- 14 years, 7 women and 3 men.
I
Intervention
Catheter ablation using 1 to 3 shocks of 100-360 J (mean total 336 +/- 195 J) delivered from a defibrillator between the tip of the ablation catheter and a patch electrode on the anterior chest, guided by pace mapping in the right ventricular outflow tract.
O
Outcome
Recurrence of symptomatic VT and inducibility of VT at electrophysiology test 7-9 days after ablationhard clinical

Catheter ablation using DC shocks is a highly effective and safe long-term treatment for idiopathic right ventricular tachycardia.

Abstract

Ten consecutive patients with recurrent episodes of symptomatic, idiopathic, sustained monomorphic ventricular tachycardia (VT) originating in the right ventricle underwent an attempt at catheter ablation of the ventricular tachycardia. There were seven women and three men, with a mean age of 39 +/- 14 years (+/- SD). None of the patients had any evidence of structural heart disease. The VT had a left bundle branch block configuration and an inferior axis in each patient, and the mean cycle length was 313 +/- 75 msec. Based on the methods of induction of the VT and the response of the VT to verapamil, the VT mechanism was presumed to be reentry in six patients, triggered activity in three patients, and catecholamine-sensitive automaticity in one patient. Sites for ablation were guided by pace mapping, and an appropriate target site was identified in the right ventricular outflow tract in each patient. From one to three shocks of 100-360 J (mean total, 336 +/- 195 J) were delivered from a defibrillator between the tip of the ablation catheter (cathode) and a patch electrode on the anterior chest (anode). An electrophysiology test 7-9 days after ablation demonstrated that VT was still inducible in only one patient, who was treated with amiodarone. One other patient had a recurrence of VT 3 weeks after ablation and was treated with verapamil. Eight of 10 patients were not treated with antiarrhythmic medications and have had no episodes of symptomatic VT during 15-68 months of follow-up (mean follow-up, 33 +/- 18 months). There were no acute or long-term complications.(ABSTRACT TRUNCATED AT 250 WORDS)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Morady et al. (1990) studied this question.

synapsesocial.com/papers/6a163f0cf508cb2fcbc1f028https://doi.org/10.1161/01.cir.82.6.2093
Ask AI
Helpful
Bookmark
Share
View Full Paper